ArticlePharmaceutics2026

CD25-Targeted Aptamer-Drug Conjugate for the Treatment of CD25-Expressing Hematological Malignancies.

Sanghyeok Woo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.